MiMedx Hammered By Activist Short Campaigns

MiMedx Hammered By Activist Short Campaigns

This year has been a rough one for activist short sellers, given the Federal Reserve’s hesitant approach to raising interest rates and the markets’ insistence on reaching ever higher levels. According to Activist Insight Online, 129 short positions had been announced by the end of August, compared to 179 last year and 172 the year before, in the same period. September’s numbers also look to be down.

Play Quizzes 4

Get Our Activist Investing Case Study!

Get the entire 10-part series on our in-depth study on activist investing in PDF. Save it to your desktop, read it on your tablet, or print it out to read anywhere! Sign up below!

In activist short campaigns, lawsuits are typically part and parcel of the process, but one announced this week touched a nerve. On Thursday, a day after short sellers Aurelius Value and Viceroy Research published near-simultaneous reports on MiMedx, the drug development and marketing company went after the source.

Fund Manager Profile: Zhang Hui Of China’s Southern Asset Management

investHistorically, the Chinese market has been relatively isolated from international investors, but much is changing there now, making China virtually impossible for the diversified investor to ignore. Earlier this year, CNBC pointed to signs that Chinese regulators may start easing up on their scrutiny of companies after months of clamping down on tech firms. That Read More

The Capitol Forum, a Washington D.C.-based research firm, pitches itself as an “in-depth news and analysis service dedicated to informing policymakers, investors, and industry stakeholders on how policy affects market competition.” According to its website, the five-year-old firm has more than 20 journalists, including editors.

MiMedx’s CEO, Pete Petit, has accused The Capitol Forum of being a “shill” for short sellers, saying his company co-operated with the group when it was putting together its analysis and provided “a significant amount of positive information.” But then, he alleges, the Forum published only negative information – “in some instances… outright lies,” and in others, “negative innuendo” – that it then sought to sell to the company’s shareholders over the phone and by email. The Capitol Forum said in an emailed comment yesterday, “The lawsuit is without merit, both legally and factually, and we will defend it vigorously.”

This wouldn’t be the first time the group’s work has been fingered as the basis for a short report. In March, its claims that TransDigm had been pushing up prices for government contracts found its way into a short campaign waged by Andrew Left’s Citron Research, which targeted FleetCor Technologies – another The Capitol Forum subject – the following month. The Forum was also named in a short report by Prescience Point Capital on Stamps.com. Yet as a basis for long-term investing, the Forum’s journalism is a poor guide – all of the stocks are up year-to-date.

Aurelius, one of the short sellers hammering away at MiMedx, was nonetheless unimpressed by the prospect of the company suing The Capitol Forum. “Bullies like Petit, who use power & influence to silence whistleblowers and corrupt our markets, must be exposed,” it tweeted. The short seller did not return a request for comment yesterday.

The short reports allege channel stuffing by the company and an investigation by the Department of Veteran Affairs, claims MiMedx says originate with two ex-employees it is currently suing. Furthermore, MiMedx says it is not the subject of the investigation and is co-operating, facts it says it told The Capitol Forum. Yet given the lawsuit came two weeks after it rebuked the Forum for its report, and only after short sellers emerged, MiMedx’s threat looks like overkill. The stock had largely recovered by Thursday’s close, illustrating why many advisers recommend that the best response to a short attack is simply to do nothing.

Article by Activist Insight

Updated on

Financial news and data providers Activist Insight and Proxy Insight announced in October 2020 that they had merged to form Insightia, a leader in the field of public company information. Activist Insight was formed in 2012 and offers an extensive range of products including Activist Insight Online, Activist Insight Governance, Activist Insight Vulnerability, Activist Insight Shorts, Activist Insight Monthly magazine, and The Activist Insight Podcast. Proxy Insight has quickly become the world’s leading source of information on global shareholder voting, covering such hot topics as director and auditor elections, “say on pay” resolutions and environmental, social, and governance (ESG) proposals.
Previous article Entry-Level Nokia 2 Might Come To Some Markets In November
Next article iPhone 8 Plus Has The World’s Best Smartphone Camera: DxOMark

No posts to display